What Is ApoB, and Should You Get It Tested?
The honest evidence on ApoB: it's a real step up from plain LDL-C, but not the clean win over non-HDL-C the headlines suggest, and the guidelines say so themselves.
In-house · synthesized from the cited primary sources
At a glance
Strong Every atherogenic particle, LDL, VLDL, IDL and Lp(a), carries exactly one apoB molecule, so ApoB counts particle number directly instead of estimating it.
What the evidence says
Understand what ApoB actually measures
Every atherogenic particle (LDL, VLDL, IDL, and Lp(a)) carries exactly one apoB molecule, so ApoB counts particle number directly. LDL-C only estimates the cholesterol cargo riding inside those particles.
Why ↓
This is the core distinction the rest of the page builds on.
ESC/EAS 2019 Guidelines, Eur Heart J 2020, section 5.4.1
See how ApoB compares to LDL-C and non-HDL-C
In a 389,529-person UK Biobank study, jointly adjusting all three lipids gave ApoB a hazard ratio of 1.27 vs 1.09 for non-HDL-C. But adjusted individually, ApoB (1.38) and non-HDL-C (1.36) were nearly identical; the authors themselves flagged the joint model's collinearity as high (VIF above 10).
Why ↓
ApoB clearly beats LDL-C. It does not clearly beat non-HDL-C, and the honest reading of the same study shows why.
Marston et al., JAMA Cardiol 2022;7(3):250-256
See what the guideline admits it does not know
The 2019 ESC/EAS guideline's own 'Gaps in the evidence' section states no outcome-based comparison of LDL-C vs ApoB exists for screening, diagnosis and management. The ESC recommendation to measure ApoB is Class I but Level C, expert consensus, not trial evidence.
Why ↓
A guideline recommending a test is not the same as a trial proving the test changes outcomes.
ESC/EAS 2019 Guidelines, Eur Heart J 2020;41(1):111-188
Understand why the two numbers can disagree
Around 20% of people show discordance between measured LDL-C and ApoB levels (ESC/EAS 2019, verbatim). At a fixed LDL-C of 100 mg/dL, 95% of people range from ApoB 66 to 99 mg/dL.
Why ↓
Discordance is the practical reason to know your own ApoB rather than assume it tracks your LDL-C.
Sayed et al., JAMA Cardiol 2024;9(8):741-747
Separate a lab's normal range from a clinical target
US lab reference ranges (roughly 60 to 133 mg/dL) describe the general population, including people who go on to have heart attacks. Treatment thresholds are stricter and depend on individual risk, a conversation for a physician, not a number to self-target.
Why ↓
'Normal' on a lab report and 'optimal' for your risk are not the same number.
NLA 2024; NHANES 2005-2016
Check whether ApoB is worth asking for
Fasting is not required (post-meal chylomicron particles are under 1% of circulating ApoB). The assay is standardized and inexpensive to run, but it is usually ordered separately from a routine lipid panel, and insurers sometimes deny or require prior authorization for it.
Why ↓
Cheap to run is not the same as automatically ordered or automatically covered.
ESC/EAS 2019; NLA 2024
The evidence 4
Strong Every atherogenic particle, LDL, VLDL, IDL and Lp(a), carries exactly one apoB molecule, so ApoB counts particle number directly instead of estimating it.
2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia
Association of Apolipoprotein B With Cardiovascular Risk (Marston et al., JAMA Cardiology, 2022)
Lipoprotein Discordance at a Given LDL-C (Sayed et al., JAMA Cardiology, 2024)
Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Editorial disclosure. This protocol is written and fact-checked by the YourProtocol editorial team directly from the primary sources cited below; it is not written or reviewed by any outside expert.
Is this for you
- Anyone who has heard 'ApoB is better than LDL' and wants the honest version
- People deciding whether to ask a doctor to add ApoB to their next panel
- Anyone comparing ApoB and non-HDL-C results that seem to disagree
Cautions
- This page is educational only: it gives no personal target number and is not a substitute for a physician's interpretation of your own results
- ApoB beats LDL-C, but it does not clearly beat non-HDL-C once lipids are adjusted individually, that nuance is easy to lose in headline summaries
- Genetic studies linking ApoB to heart disease cannot fully separate ApoB's effect from the cholesterol it carries, so 'linked to' is the accurate phrase, not 'causes'
Common questions
What does ApoB actually measure that LDL-C doesn't?
Every artery-clogging particle (LDL, VLDL, IDL, Lp(a)) carries exactly one apoB molecule, so ApoB counts particle number directly. LDL-C only estimates the cholesterol riding inside those particles.
Is ApoB definitely better than non-HDL-C?
Not clearly. In the largest head-to-head study, ApoB only outperformed non-HDL-C in a statistical model combining all three lipids at once, a model the authors themselves flagged for high collinearity (VIF above 10). Tested individually, the two performed almost identically.
Do I need to fast before an ApoB test?
No. The ESC/EAS guidelines note that after a meal, the chylomicron particles that would distort the count make up less than 1% of circulating ApoB.
What's a normal ApoB level?
US lab reference ranges (roughly 60 to 133 mg/dL) describe the general population, including people who go on to have heart attacks. Clinical treatment thresholds are stricter and depend on your individual risk, which is a conversation for your doctor, not a number to self-target.
Will my doctor test ApoB automatically?
Usually not. It's typically ordered separately from a standard lipid panel, and insurers sometimes deny or require prior authorization for it.
Does a high ApoB mean I'll definitely get heart disease?
It's linked to risk and is the strongest single lipid predictor studied, but genetic (Mendelian randomization) studies can't fully separate ApoB's effect from the cholesterol it carries, so the honest phrasing is 'linked to,' not 'causes.'